Blocklaw Consulting is a legal and regulatory advisory firm focused on digital assets, fintech, financial regulation, and emerging technologies. We provide research-driven legal analysis, compliance advisory, and regulatory strategy to businesses, institutions, and policymakers.
Blocklaw Consulting primarily provides advisory, regulatory, and policy-focused services. Where representation is required, we work through appropriate legal channels or collaborate with licensed law firms, depending on the nature of the engagement and jurisdiction.
We work with startups, financial institutions, virtual asset service providers, fintech companies, investors, and public-sector stakeholders seeking clarity on regulatory and compliance issues relating to digital assets and financial innovation.
While Nigeria is a core focus, Blocklaw Consulting also engages with comparative and cross-border regulatory frameworks, including developments in Africa, the United States, Europe, and other jurisdictions relevant to digital asset and fintech regulation.
Yes. We provide regulatory assessments, compliance guidance, and strategic advisory for virtual asset service providers and fintech firms, including assistance with licensing frameworks, regulatory engagement, and compliance planning.
Yes. Blocklaw Consulting conducts regulatory research, policy analysis, and comparative legal studies that contribute to discussions around digital asset regulation, financial innovation, and market governance.
Yes. We regularly publish commentaries, digests, and analytical pieces on digital asset regulation, enforcement developments, and emerging legal issues through our website and social platforms.
Engagements typically begin through an initial consultation or inquiry via our website or official contact channels. Each engagement is structured based on scope, regulatory focus, and client needs.
Yes. We work with early-stage and growth-stage companies, particularly those navigating regulatory uncertainty in digital assets and fintech, and provide structured guidance appropriate to their stage and risk profile.